impaired degradation mutant alpha-synuclein chaperone-mediated autophagy
aberrant alpha-synuclein degradation implicated parkinsons disease pathogenesis protein accumulates lewy inclusion bodies associated disease little known however pathways wild-type alpha-synuclein normally degraded found wild-type alpha-synuclein selectively translocated lysosomes degradation chaperone-mediated autophagy pathway pathogenic a53t a30p alpha-synuctein mutants bound receptor pathway lysosomal membrane appeared act uptake blockers inhibiting degradation substrates findings may underlie toxic gain-of-function mutants
